There's much to like about this announcement:
"The BTX 1503 Phase 2 clinical trials are designed to deliver data that allows Botanix to explore licensing and other corporate opportunities. "
- Forums
- ASX - By Stock
- BOT
- Ann: Appendix 4C - quarterly
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
2.27%
!
2.2¢
Ann: Appendix 4C - quarterly, page-4
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
